Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products- Real-World Analysis in Japan
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.848
https://www.valueinhealthjournal.com/article/S1098-3015(18)33205-4/fulltext
Title :
Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products- Real-World Analysis in Japan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33205-4&doi=10.1016/j.jval.2018.07.848
First page :
Section Title :
Open access? :
No
Section Order :
78